What was the most commonly reported adverse effect in Champix (varenicline tartrate) clinical studies?

Nausea, reported in 28.6% of patients taking Champix (varenicline tartrate) at 1 mg twice daily after initial titration, was the most commonly reported adverse event and was usually early, mild to moderate, and seldom led to discontinuation.